BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

132 related articles for article (PubMed ID: 14709046)

  • 1. A highly potent non-nucleoside adenosine deaminase inhibitor: efficient drug discovery by intentional lead hybridization.
    Terasaka T; Kinoshita T; Kuno M; Nakanishi I
    J Am Chem Soc; 2004 Jan; 126(1):34-5. PubMed ID: 14709046
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Structure-based design and synthesis of non-nucleoside, potent, and orally bioavailable adenosine deaminase inhibitors.
    Terasaka T; Okumura H; Tsuji K; Kato T; Nakanishi I; Kinoshita T; Kato Y; Kuno M; Seki N; Naoe Y; Inoue T; Tanaka K; Nakamura K
    J Med Chem; 2004 May; 47(11):2728-31. PubMed ID: 15139750
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Structure-based design, synthesis, and structure-activity relationship studies of novel non-nucleoside adenosine deaminase inhibitors.
    Terasaka T; Kinoshita T; Kuno M; Seki N; Tanaka K; Nakanishi I
    J Med Chem; 2004 Jul; 47(15):3730-43. PubMed ID: 15239652
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Rational design of non-nucleoside, potent, and orally bioavailable adenosine deaminase inhibitors: predicting enzyme conformational change and metabolism.
    Terasaka T; Tsuji K; Kato T; Nakanishi I; Kinoshita T; Kato Y; Kuno M; Inoue T; Tanaka K; Nakamura K
    J Med Chem; 2005 Jul; 48(15):4750-3. PubMed ID: 16033254
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Effect of a chemical modification on the hydrated adenosine intermediate produced by adenosine deaminase and a model reaction for a potential mechanism of action of 5-aminoimidazole ribonucleotide carboxylase.
    Groziak MP; Huan ZW; Ding H; Meng Z; Stevens WC; Robinson PD
    J Med Chem; 1997 Oct; 40(21):3336-45. PubMed ID: 9341908
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Calf spleen purine-nucleoside phosphorylase: crystal structure of the binary complex with a potent multisubstrate analogue inhibitor.
    Luić M; Koellner G; Yokomatsu T; Shibuya S; Bzowska A
    Acta Crystallogr D Biol Crystallogr; 2004 Aug; 60(Pt 8):1417-24. PubMed ID: 15272165
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Non-linear quantitative structure-activity relationship for adenine derivatives as competitive inhibitors of adenosine deaminase.
    Sadat Hayatshahi SH; Abdolmaleki P; Safarian S; Khajeh K
    Biochem Biophys Res Commun; 2005 Dec; 338(2):1137-42. PubMed ID: 16256072
    [TBL] [Abstract][Full Text] [Related]  

  • 8. In-depth study of tripeptide-based alpha-ketoheterocycles as inhibitors of thrombin. Effective utilization of the S1' subsite and its implications to structure-based drug design.
    Costanzo MJ; Almond HR; Hecker LR; Schott MR; Yabut SC; Zhang HC; Andrade-Gordon P; Corcoran TW; Giardino EC; Kauffman JA; Lewis JM; de Garavilla L; Haertlein BJ; Maryanoff BE
    J Med Chem; 2005 Mar; 48(6):1984-2008. PubMed ID: 15771442
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Fructose-1,6-bisphosphatase Inhibitors. 2. Design, synthesis, and structure-activity relationship of a series of phosphonic acid containing benzimidazoles that function as 5'-adenosinemonophosphate (AMP) mimics.
    Dang Q; Kasibhatla SR; Xiao W; Liu Y; Dare J; Taplin F; Reddy KR; Scarlato GR; Gibson T; van Poelje PD; Potter SC; Erion MD
    J Med Chem; 2010 Jan; 53(1):441-51. PubMed ID: 20055427
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Rational design of polymerase inhibitors as antiviral drugs.
    Oberg B
    Antiviral Res; 2006 Sep; 71(2-3):90-5. PubMed ID: 16820225
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Binding free energy calculations of adenosine deaminase inhibitors.
    Coi A; Tonelli M; Ganadu ML; Bianucci AM
    Bioorg Med Chem; 2006 Apr; 14(8):2636-41. PubMed ID: 16376548
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Novel multisubstrate inhibitors of mammalian purine nucleoside phosphorylase.
    Toms AV; Wang W; Li Y; Ganem B; Ealick SE
    Acta Crystallogr D Biol Crystallogr; 2005 Nov; 61(Pt 11):1449-58. PubMed ID: 16239721
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Structure-based drug design to the discovery of new 2-aminothiazole CDK2 inhibitors.
    Vulpetti A; Casale E; Roletto F; Amici R; Villa M; Pevarello P
    J Mol Graph Model; 2006 Mar; 24(5):341-8. PubMed ID: 16260160
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Structural basis of compound recognition by adenosine deaminase.
    Kinoshita T; Nakanishi I; Terasaka T; Kuno M; Seki N; Warizaya M; Matsumura H; Inoue T; Takano K; Adachi H; Mori Y; Fujii T
    Biochemistry; 2005 Aug; 44(31):10562-9. PubMed ID: 16060665
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Computational strategies in discovering novel non-nucleoside inhibitors of HIV-1 RT.
    Barreca ML; Rao A; De Luca L; Zappalà M; Monforte AM; Maga G; Pannecouque C; Balzarini J; De Clercq E; Chimirri A; Monforte P
    J Med Chem; 2005 May; 48(9):3433-7. PubMed ID: 15857150
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Discovery and structural modification of inhibitors of methionine aminopeptidases from Escherichia coli and Saccharomyces cerevisiae.
    Luo QL; Li JY; Liu ZY; Chen LL; Li J; Qian Z; Shen Q; Li Y; Lushington GH; Ye QZ; Nan FJ
    J Med Chem; 2003 Jun; 46(13):2631-40. PubMed ID: 12801227
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Discovery and design of benzimidazolone based inhibitors of p38 MAP kinase.
    Hammach A; Barbosa A; Gaenzler FC; Fadra T; Goldberg D; Hao MH; Kroe RR; Liu P; Qian KC; Ralph M; Sarko C; Soleymanzadeh F; Moss N
    Bioorg Med Chem Lett; 2006 Dec; 16(24):6316-20. PubMed ID: 17010605
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Conformational change of adenosine deaminase during ligand-exchange in a crystal.
    Kinoshita T; Tada T; Nakanishi I
    Biochem Biophys Res Commun; 2008 Aug; 373(1):53-7. PubMed ID: 18549808
    [TBL] [Abstract][Full Text] [Related]  

  • 19. IRAK-4 inhibitors. Part II: a structure-based assessment of imidazo[1,2-a]pyridine binding.
    Buckley GM; Ceska TA; Fraser JL; Gowers L; Groom CR; Higueruelo AP; Jenkins K; Mack SR; Morgan T; Parry DM; Pitt WR; Rausch O; Richard MD; Sabin V
    Bioorg Med Chem Lett; 2008 Jun; 18(11):3291-5. PubMed ID: 18482836
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Exploiting the pyrazolo[3,4-d]pyrimidin-4-one ring system as a useful template to obtain potent adenosine deaminase inhibitors.
    La Motta C; Sartini S; Mugnaini L; Salerno S; Simorini F; Taliani S; Marini AM; Da Settimo F; Lavecchia A; Novellino E; Antonioli L; Fornai M; Blandizzi C; Del Tacca M
    J Med Chem; 2009 Mar; 52(6):1681-92. PubMed ID: 19226143
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 7.